Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
Status:
Completed
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
Patients may participate in this research study if they have glioblastoma. (a brain tumor)
that has come back after being treated. Standard treatment for this cancer is a chemotherapy
drug called bevacizumab. This research study involves bevacizumab in combination with a
special diet called the Modified Atkins Diet (MAD).
The purpose of this study is to research if patients can stay on the MAD when it is added to
the standard bevacizumab treatment.
Phase:
Early Phase 1
Details
Lead Sponsor:
Case Comprehensive Cancer Center
Collaborators:
OhioHealth Research Institute University of Cincinnati